OCALIVA® (obeticholic acid) is a prescription medicine used for the treatment of primary biliary cholangitis (PBC); its first approved treatment in nearly 20 years. Since this medicine is changing what's possible in PBC treatment, the brand had to encompass its revitalizing possibilities with a warm, energetic, and refreshing identity. 
Our team worked on a range of design solutions for this brand, but my role included the development of the logo and identity as well as its accompanying print pieces.
Client: Intercept Pharmaceuticals • Agency: Cambridge BioMarketing

On to more good stuff...

brand identity • web design
TAK by Me
brand identity • packaging
GoingClear Interactive
web design
Itaca Proyectos Sustentables
web design
Black Forest Pastry Shop
web design
web design
Old Mammoth
brand identity • album art
brand identity • web design • integrated campaign
The Science of Launch
brand identity • conference design
In This River
brand identity • album art
Back to Top